CG Pharmaceuticals Prepares to Showcase Its Ongoing Phase 2 Study for Ivaltinostat in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
/PRNewswire/ -- CG Pharmaceuticals, a company dedicated to advancing innovative therapies to improve the lives of patients with cancer, prepares to showcase...
Anna Berkenblit Prnewswire Cg Pharmaceuticals Pancreatic Cancer Action Network Pan Cg Pharmaceuticals Contact Mcg Pharmaceuticals Source Cg Pharmaceuticals Inc
Source: prnewswire.com